癌症吃褐藻醣膠真的有效嗎？褐藻糖膠的抗癌功效
褐藻醣膠最廣為人知的就是其潛在的抗癌效果，在抗癌領域有大量的研究，一些研究指出，褐藻醣膠不僅可以增加患者的幸福感，還有助於治療疾病。[1-3]
褐藻糖膠抑制癌細胞增殖
研究證實，褐藻醣膠對癌細胞有直接的體外作用。研究表明，褐藻糖膠可以誘導癌細胞發生細胞凋亡，還能引發癌細胞週期停滯，使其無法繁殖。[4-6]
人體免疫系統可清除癌細胞，而褐藻糖膠可增強免疫系統對癌細胞的清除效果。[7]此外褐藻醣膠也被證明可以增強化療藥物對癌細胞的活性，對傳統化療有輔助作用。[8]
Maritech(Marinova®)褐藻醣膠已顯示可顯著改善乳癌藥物tamoxifen對乳腺癌的治療功效。在小鼠實驗中，服用Maritech®褐藻醣膠可減少乳腺癌腫瘤的生長，與tamoxifen一起服用時可減少腫瘤大小高達26%。[9]
褐藻糖膠減少腫瘤生長、轉移
有許多動物實驗證實，經口服、靜脈注射或腹膜內施用褐藻糖膠，可顯著降低腫瘤生長速度，包括血液、卵巢、乳房、前列腺、肝臟和頭頸部癌症。[1.2]
Maritech®褐藻醣膠已被證明可降低卵巢癌細胞TOV-112D的生長。在小鼠實驗中，攝取Maritech®褐藻醣膠可使該腫瘤細胞的生長減少高達33％。[10]
一項結腸癌研究發現，使用褐藻醣膠的組別，相對於對照組降低了6倍的腫瘤重量，而壽命增加高達100％。(LMWF：低分子量褐藻醣膠；IMWF：中分子量褐藻醣膠；HMWF：高分子量褐藻醣膠。)[11]
除了癌細胞的直接抑制和免疫清除，研究還發現，褐藻醣膠可抑制淋巴管生成，有效降低癌細胞轉移的機率。[12]另外還可以透過抑制腫瘤細胞的黏附，影響癌細胞的增殖和轉移。[13]
▼使用褐藻醣膠降低轉移癌細胞(migrated cells)的數目
褐藻醣膠減少化療副作用，改善生活品質
對於癌症患者，除了成功治癒，維持良好的生活品質更是病患所重視的。人們越來越關注褐藻糖膠對於改善生活品質和改善傳統癌症治療副作用的潛力。
最近一項褐藻醣膠與常用化學療法(化療)共同施用的臨床研究表明，口服褐藻醣膠不會改變乳腺癌患者常用藥物的血清水平，在一些患者中，還觀察到化療副作用的減少。[14]
在另一項研究中，接受化療的結腸癌患者服用褐藻醣膠後疲勞減輕，且能承受更多次的療程。[15]
褐藻醣膠的攝取還可減少常伴隨化療發生的惡病質，避免癌症期間的虛弱、肌肉萎縮和脂肪流失。▼小鼠腓腸肌(Normal:正常小鼠；Tumor:膀胱癌小鼠；TGC:使用化療治療；TGCF化療藥物結合褐藻醣膠)，可發現使用褐藻醣膠結合化療，可減少小鼠肌肉流失。[16]
參考資料：
- Fitton JH, Stringer DN, Karpiniec SS. Therapies from Fucoidan: An Update. Mar Drugs. 2015 Sep 16;13(9):5920-46.[文獻連結]
- Kwak JY. Fucoidan as a marine anticancer agent in preclinical development. Mar Drugs. 2014 Jan 28;12(2):851-70.[文獻連結]
- Ray M. Lowenthal, J. Helen Fitton. Are seaweed-derived fucoidans possible future anti-cancer agents? Journal of Applied Phycology. 2015 Oct;27(5):2075–2077.[文獻連結]
- Boo HJ et al., The anticancer effect of fucoidan in PC-3 prostate cancer cells. Mar Drugs. 2013 Aug 19;11(8):2982-99.[文獻連結]
- Yamasaki Y et al., Important role of β1-integrin in fucoidan-induced apoptosis via caspase-8 activation. Biosci Biotechnol Biochem. 2012;76(6):1163-8.[文獻連結]
- Chen S, Zhao Y, Zhang Y, Zhang D. Fucoidan induces cancer cell apoptosis by modulating the endoplasmic reticulum stress cascades. PLoS One. 2014 Sep 18;9(9):e108157.[文獻連結]
- Jin JO et al., Fucoidan can function as an adjuvant in vivo to enhance dendritic cell maturation and function and promote antigen-specific T cell immune responses. PLoS One. 2014 Jun 9;9(6):e99396.[文獻連結]
- Zhang Z et al., Fucoidan extract enhances the anti-cancer activity of chemotherapeutic agents in MDA-MB-231 and MCF-7 breast cancer cells. Mar Drugs. 2013 Jan 9;11(1):81-98.[文獻連結]
- Burney M et al., Evaluation Fucoidan Extracts From Undaria pinnatifida and Fucus vesiculosus in Combination With Anticancer Drugs in Human Cancer Orthotopic Mouse Models. Integr Cancer Ther. 2017:1534735417740631.[文獻連結]
- Mathew L. B, M., Gaikwad, A., Nyshadham P, Nugent, EK., Gonzalez A, Smith JA. Preclinical Evaluation of Safety of Fucoidan Extracts From Undaria pinnatifida and Fucus vesiculosus for Use in Cancer Treatment. Integrative Cancer Therapies. 2016;1-13.[文獻連結]
- Azuma K et al., Effects of oral administration of fucoidan extracted from Cladosiphon okamuranus on tumor growth and survival time in a tumor-bearing mouse model. Mar Drugs. 2012 Oct;10(10):2337-48.[文獻連結]
- Yang Y et al., Fucoidan inhibits lymphangiogenesis by downregulating the expression of VEGFR3 and PROX1 in human lymphatic endothelial cells. Oncotarget. 2016 Jun 21;7(25):38025-38035.[文獻連結]
- Gassmann P, Kang ML, Mees ST, Haier J. In vivo tumor cell adhesion in the pulmonary microvasculature is exclusively mediated by tumor cell–endothelial cell interaction. BMC Cancer. 2010 Apr 30;10:177.[文獻連結]
- Tocaciu S et al., The Effect of Undaria pinnatifida Fucoidan on the Pharmacokinetics of Letrozole and Tamoxifen in Patients With Breast Cancer. Integr Cancer Ther. 2018 Mar;17(1):99-105.[文獻連結]
- Ikeguchi M et al., Fucoidan reduces the toxicities of chemotherapy for patients with unresectable advanced or recurrent colorectal cancer. Oncol Lett. 2011 Mar;2(2):319-322.[文獻連結]
- Chen MC et al., Combined administration of fucoidan ameliorates tumor and chemotherapy-induced skeletal muscle atrophy in bladder cancer-bearing mice. Oncotarget. 2016 Aug 9;7(32):51608-51618.[文獻連結]
